New strategic partnership to develop AI-driven personalised nutrition platform

Date: 22.11.2022Source: IFF

IFF has today announced its plans for accelerated entry into the personalised nutrition sector through a strategic partnership with Salus Optima, a British-based, digitally-enabled personalised nutrition, health and wellness company. The initial focus for the partnership will be metabolic health, including obesity, pre-diabetes, high cholesterol and pre-hypertension, which impacts over 25 percent1 of the adult population globally.

Said Nicolas Mirzayantz, president, Nourish, IFF: “The partnership with Salus Optima places us at the forefront of the personalized nutrition space. It is a testament to our commitment to science, creativity and redefining possibilities with our customers and consumers at the centre of it. Our novel approach, an end-to-end personalised nutrition offering with best-in-class ingredient and flavour solutions, together with a scalable digital capability is critical to meet the needs of consumers.”

Key to the success of the personalised nutrition offering is blending science-backed, data driven recommendations with behavioural change techniques, such as digital coaching, with branded products at the core of the offering.

Added Sébastien Guery, vice president, IFF Health: “We see digital services as an enhancement to, not a replacement for, the overall personalised nutrition market. Products will always remain a critical part of health and wellness, but we also recognise the challenge our customers have in meeting the needs of their consumers when it comes to personalisation. IFF’s partnership with Salus Optima will enable our customers to empower consumers to make sustainable lifestyle choices to achieve their personal health and wellness goals with the blend of a physical product and a digital platform.”

Apart from the digital platform, IFF will collaborate with brand owners to craft specialised wellness products for consumers, incorporating the company’s extensive portfolio of science-backed and clinically tested ingredients, such as probiotics, prebiotics, plant proteins and fibres.

Said Madhusudan Patel, director, venturing and tech sourcing, Global R&D, IFF: “By combining IFF’s science-led, high-quality, clinically-studied ingredients and applications expertise with Salus Optima’s world-class digital health and wellness capabilities, we invest in technology that drives the industry forward.” 

Concluded Rodrigo Jesus, Salus Optima CEO: “At Salus Optima, our mission is to help solve some of the world’s most pressing public health issues by using technology to democratise best in class-science and amplify human touch through digital coaching and behavioural change. Deploying this technology on mobile phones and wearables tackles head on the challenge many consumers face such as accessibility, convenience and cost. By collaborating with IFF, Salus is confident that we can empower individuals to make simple and sustainable food, supplement and lifestyle choices for better human health.”  For more visit iff.com.

David Cox / IDM

Print article (with images) Print article (without images)


Always stay up to date and sign up for our newsletter service: